|
Early-Bird registration deadline - TBA
Deadline for oral and poster only abstract submissions - TBA
The Lorne Cancer Conference celebrated it's 20th Anniversary in February 2008 with great success. Have a look at the truly amazing list of invited speakers who came along to help us celebrate. Invited Speakers Mike Bishop, University of California, USA Norbert Perrimon, Department of Genetics, Harvard Medical School, USA Phil Sharp, Massachusetts Institute of Technology, USA David Ashley, Childrens Cancer Centre, Royal Childrens Hospital, Australia Alan Ashworth, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, UK Anton Berns, Molecular Genetics, The Netherlands Cancer Institute, The Netherlands David Bowtell, Peter MacCullum Cancer Research Centre, Australia Tony Burgess, Ludwig Institute for Cancer Research, Australia Lewis Cantley, Beth Israel Deaconess Medical Center, Harvard Medical School, USA Georgia Chenevix-Trench, Queensland Institute of Medical Research, Australia Suzanne Cory, The Walter and Eliza Hall Institute of Medical Research, Australia Ashley Dunn, The University of Melbourne, Australia John Forbes, Australian New Zealand Breast Cancer Group, Australia Ian Frazer, The Diamantina Institute for Cancer, Immunology & Metabolic Medicine, University of Queensland, Australia Doug Hilton, The Walter and Eliza Hall Institute of Medical Research, Australia Peter Klinken, Western Australian Institute for Medical Research, Australia David Lane, Institute of Molecular and Cell Biology, Singapore Ira Mellman, Genentech Inc, USA Junia Melo, Imperial College London, United Kingdom Ben Neel, Beth Israel Deaconess Medical Centre, Harvard Medical School, USA Nelly Polyak, Dana-Farber Cancer Institute, Harvard Medical School, USA Roger Reddel, Children's Medical Research Institute, University of Sydney, Australia Mike Stratton, The Wellcome Trust Sanger Institute, United Kingdom Brandon Wainwright, IMB, University of Queensland, Australia |